HK1084398A1 - Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors - Google Patents

Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors

Info

Publication number
HK1084398A1
HK1084398A1 HK06106732A HK06106732A HK1084398A1 HK 1084398 A1 HK1084398 A1 HK 1084398A1 HK 06106732 A HK06106732 A HK 06106732A HK 06106732 A HK06106732 A HK 06106732A HK 1084398 A1 HK1084398 A1 HK 1084398A1
Authority
HK
Hong Kong
Prior art keywords
pde
quinoline
inhibitors
synthesis
preparation
Prior art date
Application number
HK06106732A
Other languages
English (en)
Inventor
Wenxue Wu
David R Andrews
Anantha Sudhakar
Suhan Tang
Sami Y Kalliney
Christopher Nielsen
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1084398A1 publication Critical patent/HK1084398A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632—Organic additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ceramic Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Structural Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
HK06106732A 2003-09-15 2006-06-13 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors HK1084398A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50310803P 2003-09-15 2003-09-15
PCT/US2004/029773 WO2005028471A1 (en) 2003-09-15 2004-09-13 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors

Publications (1)

Publication Number Publication Date
HK1084398A1 true HK1084398A1 (en) 2006-07-28

Family

ID=34375311

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106732A HK1084398A1 (en) 2003-09-15 2006-06-13 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors

Country Status (12)

Country Link
US (1) US7129357B2 (de)
EP (1) EP1664024B1 (de)
JP (1) JP2007505834A (de)
CN (1) CN1878765A (de)
AT (1) ATE366728T1 (de)
CA (1) CA2538591A1 (de)
DE (1) DE602004007531T2 (de)
ES (1) ES2286685T3 (de)
HK (1) HK1084398A1 (de)
MX (1) MXPA06002917A (de)
WO (1) WO2005028471A1 (de)
ZA (1) ZA200602155B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126557A (en) * 1996-05-20 2002-09-12 Darwin Discovery Ltd Quinoline (thio) carboxamides inhibiting TNF or PDE-IV and pharmaceutical preparations containing them
US6262070B1 (en) * 1998-11-04 2001-07-17 Darwin Discovery Ltd. Heterocyclic compounds and their therapeutic use
GB9824160D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
US6211243B1 (en) * 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions

Also Published As

Publication number Publication date
ATE366728T1 (de) 2007-08-15
EP1664024A1 (de) 2006-06-07
ZA200602155B (en) 2007-09-26
US20050124655A1 (en) 2005-06-09
CA2538591A1 (en) 2005-03-31
ES2286685T3 (es) 2007-12-01
DE602004007531D1 (de) 2007-08-23
DE602004007531T2 (de) 2008-03-13
MXPA06002917A (es) 2006-05-31
CN1878765A (zh) 2006-12-13
WO2005028471A1 (en) 2005-03-31
EP1664024B1 (de) 2007-07-11
JP2007505834A (ja) 2007-03-15
US7129357B2 (en) 2006-10-31

Similar Documents

Publication Publication Date Title
GEP20094664B (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
TW200640913A (en) 5-Substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
TW200635917A (en) Novel compounds
TNSN07466A1 (en) Formulation of a thienopyridine platelet aggregation inhibitor
MX2007007025A (es) Nuevos derivados de hidantoina como inhibidores de metaloproteinasa.
UA93425C2 (ru) Производные гидантоина, которые применяются kak mmp ингибиторы
TW200716511A (en) New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
IL166425A0 (en) Aryl-substituted diazabicyclkanes as nicotinic acetylcholine agonists
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
PL1758852T3 (pl) Podstawione związki cyklopentenu
TW200605888A (en) Novel compounds
AU2010332955A8 (en) 3,4,4A,10B-tetrahydro-1H-thiopyrano-[4, 3-c] isoquinoline derivatives
MXPA05008183A (es) Proceso para preparar pirrolotriazina como inhibidores de cinasa.
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
WO2005005389A3 (en) Malonamide derivatives
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
SG153856A1 (en) Chemical process
MX2007007899A (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
RS20050563A (en) Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
HK1084398A1 (en) Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors
GB0320738D0 (en) Novel process
AU2001293791A1 (en) Process for the preparation of vitronectin receptor antagonists
TW200730524A (en) Process for making heteroaryl amine intermediate compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100913